Pfizer to chop billions from R&D

Fiercebiotech reports here that Pfizer is planning to cut R&D spending by $3 Billion by 2012.

I have felt for years that the Big Pharma business model was no longer valid in the current environment. Bigger is no longer better.

What does that mean for an R&D Chemist/Scientist in Pharma?

It means that while no company is 100% guaranteed secure and stable....going forward....you will have more relative security and stability in the smaller and mid-sized Pharma/Biotech firms than you will have in Big Pharma.